The Journal of Infectious Diseases

@jidjournal.bsky.social did:plc:j7joregvysxlyvog2l3xewmp

In publication since 1904, JID is the premier global journal for original research on infectious diseases. JID is an official journal of @idsainfo.bsky.social

Bei Bluesky seit 24 Oktober 2023

Follower: 6.860
Folgt: 1
Posts: 1.158
Tage in Ranglisten: 0

Zusammenfassung

The Journal of Infectious Diseases (@jidjournal.bsky.social) ist seit 24 Oktober 2023 auf Bluesky. Das Konto hat 6.860 Follower, folgt 1 Konten und hat 1.158 Posts veröffentlicht.

Ranglisten-Platzierungen

Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.

Dieses Konto war noch in keiner Tagesrangliste.

Zuletzt gelikte Posts

Öffentliche Likes aus dem Bluesky-Netzwerk.

IDSA@idsainfo.bsky.social02.11.2026 02:07
On IDSA’s & HIVMA’s Science Speaks blog: Learn more postnatal CMV infection in preterm infants, how rates of IPD since the COVID-19 pandemic shape vaccine recommendations and other research in @jidjournal.bsky.social ready to inform clinical practice. https://bit.ly/4BBski2
Post anzeigen
IDSA@idsainfo.bsky.social29.10.2026 15:32
On IDSA’s & HIVMA’s Science Speaks blog: Check out insights from the editors of a new, ongoing series of articles in @cidjournal.bsky.social highlighting how experienced clinicians deploy problem-solving skills to navigate complex cases. https://bit.ly/48mkxr0
Post anzeigen
IDSA@idsainfo.bsky.social10.10.2026 00:43
What happens when an antiviral works by causing mutations? In a new Let’s Talk ID episode, JID Deputy Editor Jonathan Li, MD, FIDSA talks the science behind molnupiravir and a recent paper that raised questions about its potential effects in mammalian cells. Watch: www.idsociety.org/multimedia/p...
Post anzeigen
IDSA@idsainfo.bsky.social08.10.2026 00:51
On IDSA’s & HIVMA’s Science Speaks: Learn more about the efficacy of switching to doravirine/islatravir, how immunocompromised individuals hospitalized with COVID-19 remain at increased mortality risk and other research in @jidjournal.bsky.social to inform clinical practice. https://bit.ly/4AYYFzi
Post anzeigen
IDSA@idsainfo.bsky.social01.07.2026 16:27
On IDSA’s & HIVMA’s Science Speaks blog: Learn about the poor antimalarial efficacy of IPTp-SP, how starting HIV treatment in early life can significantly reduce the size of the HIV reservoir and other new research in JID that’s ready to inform clinical practice. https://bit.ly/3SI2GGA
Post anzeigen

Melde dich an, um mehr zu sehen

Blockierte Konten

Blockierungen sind auf Bluesky öffentlich.

Dieses Konto blockiert niemanden.